January 24, 2008 - Mauna Kea Technologies, an in-vivo cellular imaging company, announced the closing of a $30 million financing round, the proceeds of which will be used to expand commercialization of the company’s Cellvizio technology in the U.S. and Europe, as well as to advance additional clinical applications of the platform.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now